From: Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis
Response rate
Group A (3 drugs; n.pts 195)
Group B (2 drugs; n.pts 192)
CR
4 (2 %)
3 (1.5 %)
PR
82 (42 %)
54 (28.1 %)
ORR (CR + PR)
86 (44 %)
57 (29.6 %)
p = 0.005
SD
52 (26.7 %)
56 (29.3 %)
PD
57 (29.3 %)
79 (41.1 %)